Cargando…
Transplantation of Neuronal-Primed Human Bone Marrow Mesenchymal Stem Cells in Hemiparkinsonian Rodents
Bone marrow-derived human mesenchymal stem cells (hMSCs) have shown promise in in vitro neuronal differentiation and in cellular therapy for neurodegenerative disorders, including Parkinson' disease. However, the effects of intracerebral transplantation are not well defined, and studies do not...
Autores principales: | Khoo, Melissa L. M., Tao, Helen, Meedeniya, Adrian C. B., Mackay-Sim, Alan, Ma, David D. F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100305/ https://www.ncbi.nlm.nih.gov/pubmed/21625433 http://dx.doi.org/10.1371/journal.pone.0019025 |
Ejemplares similares
-
Adipsin promotes bone marrow adiposity by priming mesenchymal stem cells
por: Aaron, Nicole, et al.
Publicado: (2021) -
Protection of dopaminergic neurons in hemiparkinsonian monkeys by flavouring ingredient glyceryl tribenzoate
por: Rangasamy, Suresh B., et al.
Publicado: (2022) -
Roles of Motor Cortex Neuron Classes in Reach-Related Modulation for Hemiparkinsonian Rats
por: Li, Min, et al.
Publicado: (2021) -
Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells
por: Kawai, Hotaka, et al.
Publicado: (2023) -
Reconstruction of Drug-induced Cleft Palate Using Bone Marrow Mesenchymal Stem Cell in Rodents
por: Amalraj, Julie Christy, et al.
Publicado: (2017)